[go: up one dir, main page]

ECSP034516A - PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS - Google Patents

PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Info

Publication number
ECSP034516A
ECSP034516A ECSP034516A ECSP034516A EC SP034516 A ECSP034516 A EC SP034516A EC SP034516 A ECSP034516 A EC SP034516A EC SP034516 A ECSP034516 A EC SP034516A
Authority
EC
Ecuador
Prior art keywords
compounds used
inhibitors
protein
compounds
relates
Prior art date
Application number
Other languages
Spanish (es)
Inventor
David Kay
Marion W Wannamaker
Ronald Marcelius Knegtel
David Bebbington
Robert Davies
Pan Li
Cornelia Forester
Albert Pierce
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ECSP034516A publication Critical patent/ECSP034516A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La presente invención se encuentra dentro del campo de la química medicinal y se relaciona a compuestos que son inhibidores de proteína quinasa, composiciones que contienen dichos compuestos y métodos de uso. Mas particularmente, esta invención se relaciona a compuestos que son inhibidores de GSK-3 y Aurora-2 proteína quinasas. La invención también se relaciona a métodos para tratar enfermedades asociadas con estas protein quinasas, tal es como diabetes, cáncer y enfermedad de Alzheimer.The present invention is within the field of medicinal chemistry and relates to compounds that are protein kinase inhibitors, compositions containing said compounds and methods of use. More particularly, this invention relates to compounds that are inhibitors of GSK-3 and Aurora-2 protein kinases. The invention also relates to methods for treating diseases associated with these protein kinases, such as diabetes, cancer and Alzheimer's disease.

ECSP034516 2000-09-15 2003-03-14 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS ECSP034516A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23279500P 2000-09-15 2000-09-15

Publications (1)

Publication Number Publication Date
ECSP034516A true ECSP034516A (en) 2003-04-25

Family

ID=32849357

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034516 ECSP034516A (en) 2000-09-15 2003-03-14 PIRAZOL COMPOUNDS USED AS PROTEIN QUINASA INHIBITORS

Country Status (3)

Country Link
CN (1) CN1926132B (en)
EC (1) ECSP034516A (en)
ZA (8) ZA200301701B (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133081A (en) * 1964-05-12 J-aminoindazole derivatives
US3935183A (en) * 1970-01-26 1976-01-27 Imperial Chemical Industries Limited Indazole-azo phenyl compounds
US3998951A (en) * 1974-03-13 1976-12-21 Fmc Corporation Substituted 2-arylquinazolines as fungicides
DE2458965C3 (en) * 1974-12-13 1979-10-11 Bayer Ag, 5090 Leverkusen 3-Amino-indazole-N-carboxylic acid derivatives, process for their preparation and pharmaceuticals containing them
DOP1981004033A (en) * 1980-12-23 1990-12-29 Ciba Geigy Ag PROCEDURE TO PROTECT CROP PLANTS FROM PHYTOTOXIC ACTION OF HERBICIDES.
US5597920A (en) * 1992-04-30 1997-01-28 Neurogen Corporation Gabaa receptor subtypes and methods for screening drug compounds using imidazoquinoxalines and pyrrolopyrimidines to bind to gabaa receptor subtypes
IL117659A (en) * 1995-04-13 2000-12-06 Dainippon Pharmaceutical Co Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same
PL204628B1 (en) * 1998-06-02 2010-01-29 Osi Pharmaceuticals PYRROLO[2,3d]PYRIMIDINE COMPOSITIONS AND THEIR USE
CA2400447C (en) * 2000-02-17 2008-04-22 Amgen Inc. Kinase inhibitors

Also Published As

Publication number Publication date
ZA200301700B (en) 2004-03-01
ZA200301703B (en) 2004-03-02
ZA200301698B (en) 2004-03-02
ZA200301704B (en) 2004-03-01
ZA200301699B (en) 2004-03-01
ZA200301702B (en) 2004-03-01
ZA200301697B (en) 2004-03-01
CN1926132B (en) 2010-12-29
CN1926132A (en) 2007-03-07
ZA200301701B (en) 2004-03-01

Similar Documents

Publication Publication Date Title
BRPI0207961A8 (en) USE OF EPOTHYLONE AND CAPECITABIN ANALOGS TO MANUFACTURE DRUG TO TREAT SOLID CANCEROUS TUMORS AND KIT COMPRISING THE SAID COMPOUNDS.
UY28130A1 (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBR PROTEINKINASES, AND PROCEDURES FOR USE.
UY38742A (en) 2,3,5-PYRAZOLO [1,5-A] PYRIMIDINE TRISUSTITUED COMPOUNDS
BR9911482A (en) Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BRPI0507644A (en) pyrazolopyrimidines as cyclin-dependent kinase inhibitors
MXPA05012573A (en) Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors.
DE602004014170D1 (en) BENZYL ETHER AND BENZYLAMINO BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE
ES2170104T3 (en) INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS.
ECSP077324A (en) BICYCLIC AMIDAS AS INHIBITORS OF CINASA
ATE358668T1 (en) DRUGS USED TO TREAT MALIGNANT TUMORS
CO5271715A1 (en) 7-AZA-INDOLIN-2-WAVES SUBSTITUTED IN 4 AND ITS USE AS PROTEIUNA QUINASA INHIBITORS
BR0008365A (en) 2-amino-6-anilino-purines and their use as medicine
WO2006044497A3 (en) Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
CR11149A (en) METABOLITES OF THE JANUS QUINASA INHIBITOR (R) -3- (4- (7H-PIRROLO [2,3-d] PIRIMIDIN-4-IL) -1H-PIRAZOL-1-IL) -3-CYCLOPENTILPROPANONITRILE
ECSP055609A (en) "Use of IkB-kinase inhibitors for the treatment of pain"
PA8583401A1 (en) NEW TRIAZOL COMPOUNDS AS INHIBITORS OF THE TRANSFORMING GROWTH FACTOR (TGF)
EA202092154A1 (en) COMBINATION THERAPY
BR0209127A (en) compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds
ATE517861T1 (en) BENZYL ETHER AND BENZYLAMIN COMPOUNDS AS INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
UA83691C2 (en) Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease
DE60021381D1 (en) CHINONIC COMPOUNDS FOR THE TREATMENT OF DISEASES
DE60033649D1 (en) COMPOUNDS AND THERAPEUTIC METHODS
ECSP11005642A (en) NEW PIRAZOLOPIRIMIDINAS AS CYCLINE DEPENDENT QUINASA INHIBITORS
BRPI0407611A (en) anti-cancer agent comprising protein lk8 as an active ingredient